Floctafenine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C20H17F3N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O04HVX6A9Q, chemically known as 2,3-dihydroxypropyl n-(8-(trifluoromethyl)-4-quinolyl)anthranilate but generally known as floctafenine, which bears US NIH Compound Identifier 3360. European Medicines Agency schedules Floctafenine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07645MIG. The term FLOCTAFENINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules floctafenine in its Anatomical Therapeutic Chemical (ATC) Classification. FLOCTAFENINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule floctafenine under HS 29334990 and SITC 51575. As of Q4 2014, FLOCTAFENINE remains the US FDA Preferred Term for this commodity. Floctafenine bears US NLM identifiers UMLS ID C0016245 and NCI Concept Code C80553. SMILES: FC(F)(F)C1C2NCCC(NC3C(CCCC3)C(=O)OCC(O)CO)C2CCC1.